ASCI
You are here: Skip Navigation LinksHome > HCP > ASCI

Cancer immunotherapy

ASCI

ASCI Clinical trials

Slide decks & videos

Patient website

Website dedicated to help patients, their family and friends about the cancer immunotherapeutic approach in an easy-to-understand format.

Visit Patient website

MAGRIT trial

Website providing information about the now recruiting Non-Small Cell Lung Cancer phase III clinical study

www.ascitrials.com

ASCI, a novel approach to cancer treatment

  • The access to this website is restricted to healthcare professionals. If you want to get full access, please login or register below.

This section introduces Antigen-Specific Cancer Immunotherapeutics (ASCI), its expected benefits as a potential new cancer treatment and its roles:

  • ASCI aims at treating cancers through targeting of tumor antigens.
  • ASCI is specifically formulated to trigger a specific immune response to eliminate the tumor cells.

New user?

Welcome to www.gsk-asci.com

If this is your first time at this site, please click here to register.

Register now

Why register?

For legal reasons, this page is intended solely for healthcare professionals. This is why we ask you to register.

Last update: 27-May-2009
ASCIs are investigational compounds